<%server.execute "isdev.asp"%> Genome-wide association study in craniosynostosis condition using innovative systematic bioinformatic analysis tools and techniques: Future prospective and clinical practice Barik M, Bajpai M, Malhotra A, Samantaray JC, Dwivedi S, Das S - J Pediatr Neurosci
home : about us : ahead of print : current issue : archives search instructions : subscriptionLogin 
Users online: 81      Small font sizeDefault font sizeIncrease font size Print this page Email this page

  Table of Contents    
Year : 2018  |  Volume : 13  |  Issue : 2  |  Page : 170-175

Genome-wide association study in craniosynostosis condition using innovative systematic bioinformatic analysis tools and techniques: Future prospective and clinical practice

1 Department of Paediatric Surgery, All India Institute of Medical Sciences, New Delhi, India
2 Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India
3 Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India
4 Department of Biostatistics, All India Institute of Medical Sciences, New Delhi, India
5 Department of Cardiac Anaesthesia, All India Institute of Medical Sciences, New Delhi, India

Date of Web Publication5-Jul-2018

Correspondence Address:
Mayadhar Barik
Department of Paediatric Surgery, All India Institute of Medical Sciences (AIIMS), Ansari Nagar, New Delhi 110029
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/JPN.JPN_71_17

Rights and Permissions



Background: Craniosynostosis (CS) conditions are included with the premature fusion of one or more multiple cranial sutures. As the second leading and most common craniofacial anomaly and orofacial clefts globally. Syndromic and nonsyndromic CS (NSCS) occur as a part of a genetic syndrome unlike Apert, Crouzon, Pfeiffer, Muenke, and Saethre–Chotzen syndromes. Approximately, 90% of the cases of CS arises from NSCS group and it is now a great challenge for the researcher and neurosurgeon for Indian-origin children, a great burden worldwide. Material and Methods: Study design: Prospective study of analysis sequence pattern on CS and NSCS from January 2007 to 2018 was carried out. Inclusion criteria: Diagnosed cases in syndromic and NSCS patients between 3 months and 14 years of age either preoperative or postoperative were included in the study of both groups (syndromic and NSCS). Exclusion criteria: Patients with primary microcephaly (secondary CS), postural plagiocephaly, incomplete data, no visual perception, and who were lost to follow-up, and who had no interest to participate the study were excluded from the study. Bioinformatic analysis: We have performed systematic bioinformatic analysis for all responsible genes by combining with using through the GeneDecks, Gene Runner, DAVID, and STRING databases. Genes testing: FGF family genes, MSX genes, such as Irf6, TP63, Dlx2, Dlx5, Pax3, Pax9, Bmp4, Tgf-beta2, and Tgf-beta3 were found to be involved in Cleft lip and cleft palate (CL/P), and Fgfr2, Fgfr1, Fgfr3, and TWIST, MSX, MSX1, 2 were found to be involved in both the groups of CS (SCS + NSCS). Results: FGFR, MSX, Irf6, TP63, Dlx2, Dlx5, Pax3, Pax9, Bmp4, Tgf-beta2, and Tgf-beta3 demonstrated and find out that in CL/P, and Fgfr2, Fgfr1, Fgfr3, and Twist1 had accurate sequence data with more than accuracy of 95% reported with proper order with additional anomalies CS through newly developed tools. Conclusion: Newly developed techniques of GeneDecks, Gene Runner, DAVID, and STRING databases gave better picture to analyze the larger population, patients (SCS + NSCS) with complex genetic, maternal, parental age, environmental, and stochastic factors contributing to NSCS networking, signaling, and pathways involvement. This bioinformatic tools analyzed better prediction of CS and NSCS sequences guiding us the newer invention modalities of pattern of screening and further development of recent future application.

Keywords: Craniosynostosis (CS), genome-wide association study, nonsyndromic craniosynostosis (NSCS), sagittal synostosis, suture, whole exome sequencing (WES)

How to cite this article:
Barik M, Bajpai M, Malhotra A, Samantaray JC, Dwivedi S, Das S. Genome-wide association study in craniosynostosis condition using innovative systematic bioinformatic analysis tools and techniques: Future prospective and clinical practice. J Pediatr Neurosci 2018;13:170-5

How to cite this URL:
Barik M, Bajpai M, Malhotra A, Samantaray JC, Dwivedi S, Das S. Genome-wide association study in craniosynostosis condition using innovative systematic bioinformatic analysis tools and techniques: Future prospective and clinical practice. J Pediatr Neurosci [serial online] 2018 [cited 2022 Jan 27];13:170-5. Available from: https://www.pediatricneurosciences.com/text.asp?2018/13/2/170/235961

   Introduction Top

Craniosynostosis (CS) conditions are increasing globally.[1] CS consists of two groups: syndromic craniosynostosis (SCS) and nonsyndromic craniosynostosis (NSCS).[2] Now NSCS group of patients was developed globally. In Indian scenario, its incidence approximately is 1:1000 live births.[3] CS etiopathogenesis little complex process to understand.[4],[5],[6] The basis of multidisciplinary and lifelong care for patients with CS in different conditions were easier to understand by imaging modalities.[7] The premature fusion of metopic sutures results in the clinical phenotype of trigonocephaly were frequently occurred in India.[8] There is an association of this characteristic within the monosomy 9p syndrome was newly observed by researcher. The receptor-type protein tyrosine phosphatase gene (RPTPs) clearly. It is located in the 9p24.1p23 region and it encodes with the major component of the excitatory and inhibitory synaptic organization. We presently are considered as a good candidate gene. Because its nature is likely responsible for this form of CS. PTPRD is well-known gene to recruit multiple postsynaptic partners such as IL1RAPL1 gene. These alterations lead to nonsyndromic intellectual disability (ID)/ intelligence quotient (IQ).[9],[10]

   Materials and Methods Top

Study design: Prospective analysis of clinical records of patients with registered in CS clinic from January 2007 to January 2018 was performed.

Inclusion criteria: Diagnosed cases in SCS and NSCS patients, who were between 3 months and 14 years of age either preoperatively or postoperatively were included in the study of both groups (SCS and NSCS).

Exclusion criteria: Patients with primary microcephaly (secondary CS), postural plagiocephaly, incomplete data, no visual perception, and who were lost to follow-up and those who had no interest to participate in the study were excluded from the study.

Genetic study: Blood sample (5mL) was taken from both the parents along with the child in ethylenediaminetetraacetic acid (vial). For control, 500 healthy children of comparable age group, who belonged to the same geographical region, were included in this study. Genomic DNA was extracted from peripheral blood lymphocytes by phenol–chloroform extraction method. Primers were diagnosed with FGFR1, FGFR2, FGFR3, FGFR4, TWIST, and MSX mutations in this study, and for FGFR1 and FGFR2 gene, primers were custom-synthesized (Sigma-Aldrich Chemicals Pvt. Ltd., Bengaluru, India).

Polymerase chain reaction: The polymerase chain reaction (PCR) for each sample was performed in 0.2mL, thin-walled tubes by using 20ng of DNA. A total of 2–5 pmol of each primer, 200mm dinucleotide triphosphates, 10X PCR buffer, 1.5mm MgCl2, and 0.5 units of DyNAzyme II DNA polymerase (Thermo Scientific; Thermo Fisher Scientific is an American multinational biotechnology product development company) were used. The PCR reaction was carried out in a T-100 DNA Engine (Bio-Rad, Hercules, CA, USA). The thermal cycles were under the following conditions: 95°C for 3min, 35 cycles at 95°C for 30s, annealing temperature as in for 30s and 72°C for 1min/kb, and a final extension at 75°C for 7min. The size of the amplicons was verified by gel electrophoresis by running the PCR products on 2% agarose gel with the 100bp marker (ladder). After the successful amplification, PCR products were digested as per the manufacturer’s instructions with the respective restriction endonucleases mentioned and they were analyzed through an ethidium bromide-stained 2.0% agarose gel with 50bp ladder. Finally, PCR-purified products were sequenced with the Sanger’s dideoxy method and with recently available new tools and techniques.

   Bioinformatics Analysis Tools Top

The GeneDecks, Gene Runner, DAVID, and STRING databases were used for the sequence analysis on the sequences obtained after performed by PCR, PCR-Restriction Fragment Length Polymorphism (RFLP), and reverse transcription PCR (RT-PCR) confirmed by the potential candidate. FGFR1, FGFR2, FGFR2iiia, FGFRiiib, FGFRiiic, FGFR3, FGFR4, MSX, MSX1, MSX2, TWIST1, TWIST2 genes by combine we used to sequence testing for mutation analysis.

   Statistical Analysis Top

Statistical analysis was performed by using the software SPSS for Windows, version 14.0 (SPSS, Chicago, IL, USA). Chi-square (χ2)[2] test was applied for the assessment of association in two-dimensional contingency tables. Odds ratios and 95% confidence intervals (95% CI) were calculated to measure the relationship between a potential risk factor of cases/control status. Descriptive statistics including percentage, mean ± standard deviation were calculated. Student’s t-test and Mann–Whitney U test were used for comparisons of continuous variables. Multiple logistic regression models were used to test for interaction between various genes with environmental risk factors.

   Results Top

FGFR, MSX, IRF6, TP63, DLX2, DLX5, Pax3, PAX9, BMP4, TGF-beta2, TGF-beta3 CL/P, FGFR2, FGFR1, FGFR3, and TWIST1 with the accurate sequence data (ASD) with more than 95%. FGF family and its isomers involved with CS within (SCS and NSCS) group. Other genes enriched into involved in different signaling and pathways (80%). At the same time different craniofacial deformities and different biological process involvement 90%. FGFR1, FGFR2, FGFR2iiia, FGFRiiib, FGFRiiic, FGFR3, FGFR4, MSX, MSX1, MSX2, TWIST1, TWIST2 genes and gene network including with big data set also associated with gene environment interactions 90%. Craniofacial deformities including with different biological process make us correct analyze the function of FGF family, MSX, and other associated genes in a gene network and give appropriate sequences are enriched with big data are quite useful messages. Gene Runner provides us 98% accurate analysis, GeneDecks provides 97%, DAVID gives 96%, and STRING databases provide more than 95%. All new tools help more than excellent results to optimize the results to know the etiopathogenesis and disease progression with signaling and pathways data of CS and NSCS and associated diseases also clarified through these sequences gives better annotation.

We also describe details with boy and girl with severe ID, trigonocephaly, and dysmorphic facial features such as a midface hypoplasia, a flat nose, a depressed nasal bridge, hypertelorism, a long philtrum, and a drooping mouth, and fibroblast growth factor receptor (FGFR) syndromes newly novel mutation detected both SCS + NSCS group.[11] Microarray chromosomal analysis revealed the presence of a homozygous deletion involving the PTPRD gene, located on chromosome 9p22.3. The RT-PCR amplifications all along the genes failed to amplify the patient’s cDNA in fibroblasts because of the presence of two null PTPRD alleles.[12]

Synaptic PTPRD interacts with IL1RAPL1 which defects have been also associated with ID and autism spectrum disorder. So, absence of the PTPRD transcript leads to a decreased expression pattern of the IL1RAPL1. These interesting results suggested that direct involvement of PTPRD is seen in ID. This is consistent with the PTPRD−/− mice phenotypes.

Hence, deletions of PTPRD suggested that a cause of trigonocephaly. Patients with monosomy 9p and genome-wide association study (GWAS) suggested variations in PTPRD are associated with hearing loss (HL) and deletion identified in the reported patient supports previous hypotheses. Additionally, its function in ID and HL with IQ. However, metopic synostosis still needs to be discussed as more investigation of patients with the 9p monosomy syndrome is required other clinical conditions of both groups in SCS + NSCS.[12]

   Discussion Top

Phenotypic investigation of CS patient’s SNPs in the IL-23R gene (rs11209026, rs7517847, rs11805303, rs1004819, rs17375018) patients with lower frequency are the rs17375018 GA and AA genotypes. The rs11209026 G allele frequency is higher in male patients with CS. The rs11805303 G and rs1004819 G alleles were more frequent in patients with papulopustular lesions from different ethnic backgrounds including NSCS and CS.[13] The FGFR, TWIST, and MSX genes in a gene network gene polymorphisms were associated with nonsyndromic CL/P by GWAS. It was protein–protein interaction with FGFR, MSX1, corroborate us an alternative method to perform bioinformatic analysis (BA) for genes found by GWAS and make us predict the disrupted protein function due to the mutation in a gene DNA sequences made easier to predict. These findings may guide us to perform further functional studies in the future to know the better etiopathogenesis of these (SCS + NSCS) different associated clinically observed conditions.[14]

   Fibroblast Growth Factor Receptor 3 (FGFR3)-Associated Syndrome Top

Muenke syndrome (MS) is an FGFR3-associated syndrome. This was first described in the late 1990s. MS is an autosomal dominant disorder characterized by coronal suture CS. MS in the association with an identical gene mutation, an unique point mutation c.749C > G in exon 7 of the FGFR3 gene involved with MS.[15] Sagittal CS: Sagittal CS is the most common form of CS found in India. Children were the affected group, approximately one in every 5,000 newborn. In our knowledge, the first GWAS for nonsyndromic sagittal CS using non-Hispanic case-parent trios of Indian ancestry also studied with BMP genes. BMP2 and BBS9 and BMP genes played a role in skeletal development and specify the functional activities to further understand the etiology of NSCS.[16] We also got nearly the same picture in the Indian population in both the groups (CS and NSCS), no extraordinary changes in our results as reported earlier in the European study. We feel need sample size more.

   Craniofacial Architecture and Networking Top

The craniofacial architecture networking of the domestic dog morphed and radiated to human whims. So far, to define the genetic underpinnings of breed skull shapes is really a question mark. Here, we can elucidate the molecular mechanisms of morphological diversification in CS. CS and NSCS framework is needed for understanding the human cephalic disorder. GWAS analysis by using whole-genome sequencing uncovers a missense mutation in BMP3 and BMP4, and validation studies in the zebrafish show that BMP3 function in cranial development is the informative one.[17]

   Developmental Pathways of Horn and Strong Bone Top

Developmental pathways involved in horn development are complex and still poorly understood. The description of a new dominant inherited syndrome in the bovine Charolais breed that we have named type 2 scurs. Clinical examination revealed that despite a strong phenotypic variability. It also affected individuals show both horn abnormalities practically similar to classical scurs phenotype and skull intero frontal suture synostosis. Genome-wide linkage analysis used by the Illumina BovineSNP50 BeadChip genotyping data from 750 at half-sib and full-sib progeny.

This locus was mapped and observed that 1.7Mb interval on bovine chromosome 4. TWIST1 gene encoding that transcription factor as considered as a strong candidate gene in both animal and human CS and NSCS. Its haploinsufficiency is quite valid and responsible for the human Saethre–Chotzen syndrome (SCS). The skull coronal and biocoronal suture synostosis sequencing of the TWIST1 gene identified a c.148_157dup (p.A56RfsX87) frameshift mutation predicted to completely inactivate gene.

Parents with heterozygous mutation (HM) showed that homozygous mutant progenies are completely absent. Among these conditions and are consistent with the embryonic lethality (EL). Earlier, basic scientist reported that in Drosophila melanogaster and mouse suffering from TWIST1 complete insufficiency. Description of type 2 scurs symptoms allowed an opportunity to propose at different molecular mechanisms and to explain the features of this SCS + NSCS syndrome and ontogenesis provide an evidence that how to improve this study CS and NSCS.[18]

   Genetic Variants Identification (GVI) through Genome-Wide Association Study (GWAS) Top

Now we also implemented a breed mapping approach using by moderately dense SNP arrays. The lower number of animals and breeds were carefully selected for the phenotypes. As of interest to identify genetic variants (IGVs) are responsible for breed-defining characteristics. With the help of GWAS, one of the most striking morphological traits in dogs with brachycephalic head type was observed. Although candidate gene approaches based on comparable phenotypes with mice and humans were utilized for this trait, the causative gene has remained elusive; therefore, using this method, breeds identified strong genome-wide associations (GWAS) developed for brachycephalic head type on Cfa 1. In genotyping assay additionally, dog’s model in the region confirmed the association of the genetic structure and function. Dog breeds have primarily been exploited for GWAS, and segregating the trait results demonstrated that nonsegregating traits coming under the strong selection and equally tractable to genetic analysis using smaller number of sample sizes is a new approach for both group of SCS + NSCS sequence identification.[19]

   Fibroblast Growth Factor Receptor Family Top

HMs of three members of the fibroblast growth factor receptor family of signal transduction molecules, namely—FGFR1, FGFR2, and FGFR3—contributes significantly to disorders of bone patterning and growth of SCS + NSCS. FGFR3 mutations, predominantly, cause short-limbed bone dysplasia. CS and NSCS had three major regions (i.e., extracellular, transmembrane, and intracellular) of the protein (mainly famous for achondroplasia). The exons (IIIa and IIIc), encoding the IgIII domain and in the extracellular region, in SCS as well as NSCS. It was included with the Apert, Crouzon, or Pfeiffer syndromes (PS). Interpretation of these apparent clustering, mutations in FGFR2 has been hampered. Hence, the absence of complete FGFR2-mutation screening undertaken such a screen in 500 patients with CS. Because of FGFR2 mutations localized to the IIIa and IIIc exons, we identified mutations in seven additional exons, which included six distinct mutations of the tyrosine kinase region. Hence, the IgIIIa/IIIc region represents a genuine mutation hot spot for SCS + NSCS in our knowledge.[20]

So far considering these novelty and understanding the better concept of FGFR may be a great challenge and potential biomarkers and capable to reproduce the new inventory like gene therapy and molecular targeted therapy (MTT) to resolve this complex disorders SCS + NSCS.[21],[22] We recently developed a new protocol any one can store the cranial samples or other human samples as per laboratory use of molecular study. It could be helpful for laboratory processing and treatment as well.[23],[24] In the meanwhile, one should not ignore the medical education and recent advancement of new tools and techniques related to sample processing and handling of SCS + NSCS samples.[25],[26]

Currently, new and innovative genomic discoveries data and tools such as GeneDecks, Gene Runner, DAVID, and STRING database by using these are very easy to elucidate the genetic basis for nonsyndromic cases and implicate the newly identified genes in different signaling pathways made easy. We previously found in our SCS and NSCS epidemiologic and phenotypic studies clearly demonstrate that NSCS is a complex and heterogeneous condition supporting to new innovation through new tools a strong genetic component accompanied by environmental factors, lethality, stochastic, and other additional information by this bioinformatics tools that contribute to the best pathogeneses network of this birth defect (SCS + NSCS).

   Conclusion Top

The newly developed tools and techniques of GeneDecks, Gene Runner, DAVID, and STRING databases give a better picture to analyze the larger population. Any single, clinic or hospital-based studies is required with phenotypically homogeneous subsets of patients (SCS + NSCS) to further understand the complex genetic, maternal, parental age, environmental, and stochastic factors contributing to NSCS. Although learning about these variabilities is a key in formulating on the basis of multidisciplinary and lifelong care for patients with these conditions are quite important task. These BA tools add informative annotation to predict the sequence pattern and help the molecular study to treat the patients with CS and NSCS. It helps in the diagnosis, prognosis, and personalized medicine, and helps treatment with follow-up the study. In fact, this newly provide us new information of how to target the future opaque of MTT.


We acknowledge the funding support provided by to ICMR, India, to us in due time.

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.

   References Top

Barik M, Bajpai M, Das RR, Panda SS. Study of environmental and genetic factors in children with craniosynostosis: A case-control study. J Pediatr Neurosci 2013;13:89-92.  Back to cited text no. 1
Barik M, Bajpai M, Panda SS, Malhotra A, Samantaray JC, Dwivedi SN. Strengthening molecular genetics and training in craniosynostosis: The need of the hour. J Neurosci Rural Pract 2014;13:428-32.  Back to cited text no. 2
Barik M, Bajpai M, Das RR, Malhotra A, Panda SS, Sahoo MK, et al. Role of 99mtc-ECD SPECT in the management of children with craniosynostosis. Biomed Res Int 2014;13:172646.  Back to cited text no. 3
Mandelia A, Bajpai M, Agarwala S, Gupta AK, Kumar R, Ali A. The role of urinary TGF-β₁, TNF-α, IL-6 and microalbuminuria for monitoring therapy in posterior urethral valves. Pediatr Nephrol 2013;13:1991-2001.  Back to cited text no. 4
Barik M, Bajpai M, Malhotra A, Samantaray JC, Dwivedi SN. Craniosynostosis and genetic engineering. In: Biotechnology, gene and protein engineering. Houston, U.S.A: Studium Press; 2014. pp. 105-22.  Back to cited text no. 5
Panda SS, Bajpai M, Singh A, Baidya DK, Jana M. Foreign body in the bronchus in children: 22 Years experience in a tertiary care paediatric centre. Afr J Paediatr Surg 2014;13:252-5.  Back to cited text no. 6
Barik M, Malhotra A, Dwivedi SN, Dwivedi D, Sharma P, Bal C, et al. To compare the various imaging modalities in the diagnosis and management of children with craniosynostosis. J Nucl Med 2012;13:2206.  Back to cited text no. 7
Barik M, Bajpai M, Malhotra A, Samantary J, Dwivedi SN. 99m Tc- ECD brain SPECT are significantly correlated in patients with craniosynostosis: A case-control study. Eur J Nucl Med Mol Imaging 2013;13:S523.  Back to cited text no. 8
Heuzé Y, Holmes G, Peter I, Richtsmeier JT, Jabs EW. Closing the gap: Genetic and genomic continuum from syndromic to nonsyndromic craniosynostoses. Curr Genet Med Rep 2014;13: 135-45.  Back to cited text no. 9
Choucair N, Mignon-Ravix C, Cacciagli P, Abou Ghoch J, Fawaz A, Mégarbané A, et al. Evidence that homozygous PTPRD gene microdeletion causes trigonocephaly, hearing loss, and intellectual disability. Mol Cytogenet 2015;13:39.  Back to cited text no. 10
Barik M, Bajpai M, Malhotra A, Samantaray JC, Dwivedi S, Das S. Novel mutation detection of fibroblast growth factor receptor 1 (FGFR1) gene, FGFR2IIIA, FGFR2IIIB, FGFR2IIIC, FGFR3, FGFR4 gene for craniosynostosis: A prospective study in Asian Indian patient. J Pediatr Neurosci 2015;13:207-13.  Back to cited text no. 11
Barik M, Das RR. Should microarray technology included in medical curriculum? Indian J Biotechnol 2012;13:355-6.  Back to cited text no. 12
Yalçin B, Atakan N, Dogan S. Association of interleukin-23 receptor gene polymorphism with behçet disease. Clin Exp Dermatol 2014;13:881-7.  Back to cited text no. 13
Dai J, Mou Z, Shen S, Dong Y, Yang T, Shen SG. Bioinformatic analysis of msx1 and msx2 involved in craniofacial development. J Craniofac Surg 2014;13:129-34.  Back to cited text no. 14
Aravidis C, Konialis CP, Pangalos CG, Kosmaidou Z. A familial case of Muenke syndrome. Diverse expressivity of the FGFR3 pro252arg mutation–case report and review of the literature. J Matern Fetal Neonatal Med 2014;13:1502-6.  Back to cited text no. 15
Justice CM, Yagnik G, Kim Y, Peter I, Jabs EW, Erazo M, et al. A genome-wide association study identifies susceptibility loci for nonsyndromic sagittal craniosynostosis near BMP2 and within BBS9. Nat Genet 2012;13:1360-4.  Back to cited text no. 16
Schoenebeck JJ, Hutchinson SA, Byers A, Beale HC, Carrington B, Faden DL, et al. Variation of BMP3 contributes to dog breed skull diversity. Plos Genet 2012;13: e1002849.  Back to cited text no. 17
Capitan A, Grohs C, Weiss B, Rossignol MN, Reversé P, Eggen A. A newly described bovine type 2 scurs syndrome segregates with a frame-shift mutation in TWIST1. Plos One 2011;13:e22242.  Back to cited text no. 18
Bannasch D, Young A, Myers J, Truvé K, Dickinson P, Gregg J, et al. Localization of canine brachycephaly using an across breed mapping approach. Plos One 2010;13:e9632.  Back to cited text no. 19
Kan SH, Elanko N, Johnson D, Cornejo-Roldan L, Cook J, Reich EW, et al. Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis. Am J Hum Genet 2002;13:472-86.  Back to cited text no. 20
Barik M, Meher S,Chaudhary V. Current prospective in gene therapy and the role played by medical informatics. Indian J Med Inform 2012;13:51-66.  Back to cited text no. 21
Barik M, Bajpai M, Malhotra A, Samantary J, Dwivedi SN. Potential therapeutic strategies and its application in correcting birth defects, craniosynostosis, neurological disorders and other diseases. J Metab Syndr 2013;13:122.  Back to cited text no. 22
Barik M, Meher S. Evaluation and monitoring of meta-analysis in medical research through information technology. Indian J Med Inform 2012;13:51-66.  Back to cited text no. 23
Barik M, Bajpai M, Malhotra A, Samantaray JC, Dwivedi SN. Does cryopreservation technology helps to forensic medicine and tissue engineering? J Forensic Med Toxicol 2014;13:34-43.  Back to cited text no. 24
Barik M. Cryopreservation technology is an effective tool for clinical application and research. Clinical Epidemiology Unit, AIIMS, New Delhi, India. BMJ 2012:13:81.  Back to cited text no. 25
Barik M. In response to evolutionary change: The new face of annals of cardiac anesthesia. Ann Card Anaesth 2015;13:416.  Back to cited text no. 26

This article has been cited by
1 A Trove of Original Treasures
Garth D. Ehrlich
Genetic Testing and Molecular Biomarkers. 2021; 25(5): 307
[Pubmed] | [DOI]


Print this article  Email this article
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Article in PDF (214 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  

    Materials and Me...
    Bioinformatics A...
   Statistical Analysis
    Fibroblast Growt...
    Craniofacial Arc...
    Developmental Pa...
    Genetic Variants...
    Fibroblast Growt...

 Article Access Statistics
    PDF Downloaded77    
    Comments [Add]    
    Cited by others 1    

Recommend this journal